Hino O, Nemoto N, Nagao M, Kosugi A, Kitagawa T
Cancer Lett. 1982 Feb;15(2):131-6. doi: 10.1016/0304-3835(82)90042-8.
The influence of 3-methyl-4-(dimethylamino)azobenzene(3'-Me-DAB) on the drug-metabolizing system in the liver was investigated. Feeding of 3-Me-DAB for 3 weeks at 10, 20 and 600 ppm increased the content of hepatic microsomal cytochrome P-450 slightly (up to 27% raise) but significantly. The feeding effects were also demonstrated in S-9 activity (up to 91% raise) when the mutagenicity of 3-methylcholanthrene (3-MC) and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) was assayed in Ames system using S-9 fraction from 3'-Me-DAB-treated rat livers.
研究了3-甲基-4-(二甲基氨基)偶氮苯(3'-Me-DAB)对肝脏药物代谢系统的影响。以10、20和600 ppm的剂量给大鼠喂食3'-Me-DAB 3周,可使肝微粒体细胞色素P-450的含量略有增加(最多提高27%),但具有显著性。当使用来自3'-Me-DAB处理的大鼠肝脏的S-9组分,在艾姆斯试验系统中检测3-甲基胆蒽(3-MC)和3-氨基-1-甲基-5H-吡啶并[4,3-b]吲哚(Trp-P-2)的诱变性时,喂食效应在S-9活性方面也得到了证实(最多提高91%)。